Cargando…
Human induced pluripotent stem cell-derived mesenchymal stem cells prevent adriamycin nephropathy in mice
Human induced pluripotent stem cell-derived mesenchymal stem cells (iPS-MSCs) are emerging as attractive options for use in cell replacement therapy, but their effect in kidney diseases remains unknown. Here, we showed that intravenous injection of iPS-MSCs protect against renal function loss in bot...
Autores principales: | Wu, Hao Jia, Yiu, Wai Han, Wong, Dickson W.L., Li, Rui Xi, Chan, Loretta Y.Y., Leung, Joseph C.K., Zhang, Yuelin, Lian, Qizhou, Lai, Kar Neng, Tse, Hung Fat, Tang, Sydney C.W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732756/ https://www.ncbi.nlm.nih.gov/pubmed/29262590 http://dx.doi.org/10.18632/oncotarget.21760 |
Ejemplares similares
-
Mesenchymal Stem Cells Modulate Albumin-Induced Renal Tubular Inflammation and Fibrosis
por: Wu, Hao Jia, et al.
Publicado: (2014) -
Recent advances in the understanding and management of IgA nephropathy
por: Lai, Kar Neng, et al.
Publicado: (2016) -
Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone
por: Leung, Joseph CK, et al.
Publicado: (2011) -
Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells Attenuate Cigarette Smoke-Induced Cardiac Remodeling and Dysfunction
por: Liang, Yingmin, et al.
Publicado: (2017) -
Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure
por: Liao, Songyan, et al.
Publicado: (2019)